{"schema_version":"secwatch.filing_event.v1","accession":"0001615219-24-000079","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2024-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.783128+00:00","generated_at":"2026-05-31T01:10:34.677755+00:00","sec_items":["5.08","8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Salarius sets 2024 annual meeting for Dec 20; proposal deadline Oct 7","bullets":["Annual meeting set for December 20, 2024; record date October 25, 2024.","Stockholder proposals for proxy inclusion due October 7, 2024 (Rule 14a-8).","Advance notice for business/director nominations also due October 7, 2024.","Universal proxy rule notice deadline for director nominees is October 21, 2024.","Meeting date changed by over 30 days from last annual meeting anniversary."],"urls":{"canonical":"https://secwatch.observer/filing/0001615219-24-000079","json":"https://secwatch.observer/filing/0001615219-24-000079.json","markdown":"https://secwatch.observer/filing/0001615219-24-000079.md","text":"https://secwatch.observer/filing/0001615219-24-000079.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000161521924000079/0001615219-24-000079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000161521924000079/flks-20240927.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T01:10:34.677755+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}